Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion type Assertion NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_head.
- NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_provenance.
- NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion evidence source_evidence_literature NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_provenance.
- NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion SIO_000772 21288594 NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_provenance.
- NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion wasDerivedFrom befree-2016 NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_provenance.
- NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_assertion wasGeneratedBy ECO_0000203 NP869684.RAe4b7n_uB8qOqXB5uIriSjZtI0JeP2_ZbNNtgFakfjO4130_provenance.